⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QTRX News
Quanterix Corporation Common Stock
Nanotechnology Market Research Report 2026-2030: Strategic Initiatives by Industry Leaders and Emerging Nano-Sensor, Composite and Precision Tool Technologies Shape Future Growth
globenewswire.com
MMM
AMAT
BRKR
DD
DV
ESP
FSLR
GEHC
HPE
HON
IBM
INTC
KMB
MSFT
NOC
NVDA
QCOM
QTRX
RIVN
S
SAN
SAP
SMCI
SNPS
SPWR
T
TEL
TER
TGT
TMO
TSM
TXN
VRSN
WD
Quanta Therapeutics Presents Preclinical Data Establishing that Direct Multi-KRAS Inhibitors Retain Strong Activity Against Resistance Mechanisms Acquired from Treatment with pan-RAS Tri-Complex Inhibitors
globenewswire.com
QTRX
Quell Therapeutics Demonstrates Safety, Phenotypic Stability, Durability and Early Efficacy with Phenotype‑Locked™ CAR‑Tregs in LIBERATE Phase 1/2 Liver Transplant Study
globenewswire.com
QTRX
Form 8-K
sec.gov
QTRX
Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025
businesswire.com
QTRX
Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide
businesswire.com
QTRX
Quanterix to Participate in Upcoming Investor Conferences
businesswire.com
QTRX
MIPIアライアンス、モバイル、PC、自動車向けエッジAIにおけるJEDEC UFSの性能を加速すべくUniPro v3.0およびM-PHY v6.0をリリース
businesswire.com
GOOG
INTC
QCOM
NVDA
AAPL
AMZN
MSFT
TXN
MU
NXPI
STM
ADI
SWKS
QRVO
MCHP
ON
AEHR
KLAC
AMAT
TER
KEYS
TDY
CHKP
PANW
SNPS
CDNS
SMTC
MPWR
VRSN
ADSK
AMD
QTRX
WDC
LRCX
ASML
INFY
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
businesswire.com
QTRX
Mercy BioAnalytics Appoints Darrin Crisitello as Chief Commercial Officer
prnewswire.com
QTRX
NTRA